Cargando…
Cell Therapy With Mesenchymal Stem Cells Induces an Innate Immune Memory Response That Attenuates Experimental Colitis in the Long Term
BACKGROUND AND AIMS: Mesenchymal stem cells [MSCs] are used in preclinical and clinical studies for treatment of immune-mediated disorders, thanks to their immunomodulatory properties. Cell therapy with MSCs induces multiple effects in the immune system which ultimately lead to increase in the numbe...
Autores principales: | Lopez-Santalla, Mercedes, Hervas-Salcedo, Rosario, Fernandez-Garcia, Maria, Bueren, Juan Antonio, Garin, Marina Inmaculada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533896/ https://www.ncbi.nlm.nih.gov/pubmed/32318720 http://dx.doi.org/10.1093/ecco-jcc/jjaa079 |
Ejemplares similares
-
Adipose‐derived mesenchymal stromal cells modulate experimental autoimmune arthritis by inducing an early regulatory innate cell signature
por: Lopez‐Santalla, Mercedes, et al.
Publicado: (2016) -
Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies
por: Lopez-Santalla, Mercedes, et al.
Publicado: (2021) -
Comparative Analysis between the In Vivo Biodistribution and Therapeutic Efficacy of Adipose-Derived Mesenchymal Stromal Cells Administered Intraperitoneally in Experimental Colitis
por: Lopez-Santalla, Mercedes, et al.
Publicado: (2018) -
Enhanced Susceptibility of Galectin-1 Deficient Mice to Experimental Colitis
por: Fernandez-Perez, Raquel, et al.
Publicado: (2021) -
Biodistribution and Efficacy of Human Adipose-Derived Mesenchymal Stem Cells Following Intranodal Administration in Experimental Colitis
por: Lopez-Santalla, Mercedes, et al.
Publicado: (2017)